Organisation paid for research Program year 2025 Source: CMS Open Payments

Evolve Clinical Research LLC

Neither a doctor nor a teaching hospital

Research payments

$271,903

29 payments

Through program year 2025, Evolve Clinical Research LLC is reported as receiving $271,903 in research payments, across 29 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$10,782	3
2024	Research	$11,684	5
2023	Research	$80,759	7
2022	Research	$144,200	10
2021	Research	$24,480	4

Breakdown

Who paid Research payments · program years 2021–2025

Boston Scientific Corporation $261,122 26 payments
Teva Pharmaceuticals USA, Inc. $10,782 3 payments

Studies the money was for Research payments · program years 2021–2025

Rapid $168,679 14 payments
Rapid $92,443 12 payments
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma $10,530 1 payment
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma $252 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.